Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (311-320 of 770) with videos related to

Pageof 77
Sort By:
American Heart Journal|May 17, 2011
Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trialPaul W Armstrong, Cynthia M Westerhout, Frans Van de Werf, et al.
American Heart Journal|September 11, 2013
Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE TrialJohn H Alexander, Elliott Levy, Jack Lawrence, et al.
Circulation|August 19, 2021
Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart AssociationSheryl L Chow, Comilla Sasson, Ivor J Benjamin, et al.
Contemporary Clinical Trials|February 12, 2021
Corrigendum to "Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example" [Contemporary Clinical Trials volume 88 (2020) 105775]Siyun Yang, Monique Anderson Starks, Adrian F Hernandez, et al.
Journal of the American College of Cardiology|November 27, 2007
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trialJames A de Lemos, David A Morrow, Michael A Blazing, et al.
The American Journal of Cardiology|March 14, 2007
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shockRajendra H Mehta, Robert M Califf, Qinghong Yang, et al.
American Heart Journal|June 25, 2004
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUITWei-Ching Chang, Eric Boersma, Christopher B Granger, et al.
The American Journal of Cardiology|October 26, 2002
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)M Ashequl Islam, James C Blankenship, Craig Balog, et al.
Journal of Cardiac Failure|August 3, 2011
The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failureMonica R Shah, Robert M Califf, Anju Nohria, et al.
Journal of the American College of Cardiology|March 26, 2003
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF studyG Michael Felker, Raymond L Benza, A Bleakley Chandler, et al.
Pageof 77

Showing results (311-320 of 770) with videos related to

Sort By:
Pageof 77
American Heart Journal|May 17, 2011
Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trialPaul W Armstrong, Cynthia M Westerhout, Frans Van de Werf, et al.
American Heart Journal|September 11, 2013
Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE TrialJohn H Alexander, Elliott Levy, Jack Lawrence, et al.
Circulation|August 19, 2021
Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart AssociationSheryl L Chow, Comilla Sasson, Ivor J Benjamin, et al.
Contemporary Clinical Trials|February 12, 2021
Corrigendum to "Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example" [Contemporary Clinical Trials volume 88 (2020) 105775]Siyun Yang, Monique Anderson Starks, Adrian F Hernandez, et al.
Journal of the American College of Cardiology|November 27, 2007
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trialJames A de Lemos, David A Morrow, Michael A Blazing, et al.
The American Journal of Cardiology|March 14, 2007
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shockRajendra H Mehta, Robert M Califf, Qinghong Yang, et al.
American Heart Journal|June 25, 2004
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUITWei-Ching Chang, Eric Boersma, Christopher B Granger, et al.
The American Journal of Cardiology|October 26, 2002
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)M Ashequl Islam, James C Blankenship, Craig Balog, et al.
Journal of Cardiac Failure|August 3, 2011
The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failureMonica R Shah, Robert M Califf, Anju Nohria, et al.
Journal of the American College of Cardiology|March 26, 2003
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF studyG Michael Felker, Raymond L Benza, A Bleakley Chandler, et al.
Pageof 77